Issue Date: June 6, 2011
Biomarker Associations Often Overestimated
Most biomarkers reported as potential determinants of disease risk, disease progression, or response to treatment don’t live up to their billing as originally reported, according to a statistical analysis (J. Am. Med. Assoc., DOI: 10.1001/jama.2011.713). John P. A. Ioannidis of Stanford University School of Medicine and Orestis A. Panagiotou of the University of Ioannina School of Medicine, in Greece, examined 35 highly cited biomarker associations to find out whether the reported . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society